Effect of Sleep Extension on Body Weight and Learning in Children (More2Sleep)
More2Sleep
A Randomized Controlled Trial of Sleep Extension to Regulate Body Weight and Improve Learning in School-aged Children
2 other identifiers
interventional
142
1 country
3
Brief Summary
More2Sleep is a randomized, controlled, parallel trial with two groups (sleep extension vs control) including 142 school-aged children (6-12 years) who have a BMI above average, defined as age- and sex-specific BMI Z-score above zero using WHO reference standards, and habitually sleep for ≤ 9 h/night. Data will be collected before and after a 3-month sleep extension intervention, and after a 6-month follow-up (at months 0, 3, and 9). The collection of data is mainly related to the main study. However, some optional examinations will be conducted on a first come, first serve basis, consisting of substudy-I (metabolic mechanisms, n=60) and substudy-II (learning mechanisms, n=142). The primary objective is to assess the effects of sleep extension by \~45 min/night, achieved by going to bed 60-90 min earlier, on adiposity and learning ability in school-aged children who have a BMI for age and sex above average, and sleep less than recommended for their age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2024
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2023
CompletedFirst Posted
Study publicly available on registry
April 2, 2024
CompletedStudy Start
First participant enrolled
August 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
November 25, 2025
January 1, 2025
3.4 years
August 10, 2023
November 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
BMI Z-score
BMI (in kg/m\^2) will be calculated from weight and height (secondary outcomes), and the age- and sex-specific BMI Z-score (in units of standard deviation from the reference population mean) will be computed using international (WHO) data
Assessed at months 0, 3 and 9
Learning ability: skill learning
Skill learning ability will be measured as motor memory assessed as 24h retention after skill practice - I.e. total within and between session effect (range: from "low" = 0 to "high" = 100, unitless)
Assessed at months 0 and 3
Learning ability: Explicit memory
Explicit memory assessed as 24h retention after word list memory encoding - I.e. total within and between session effect. Number of correctly recalled words in a 2-minute standardized task (range: from 0 to 20)
Assessed at months 0 and 3
Secondary Outcomes (26)
Body fat percent
Assessed at months 0, 3 and 9
Total fat mass (FM)
Assessed at months 0, 3 and 9
Total lean mass (LM)
Assessed at months 0, 3 and 9
Bone mineral content (BMC)
Assessed at months 0, 3 and 9
Bone mineral density (BMD)
Assessed at months 0, 3 and 9
- +21 more secondary outcomes
Other Outcomes (49)
Health-related quality of life: child-reported
Assessed at months 0, 3 and 9
Health-related quality of life: parent-reported
Assessed at months 0, 3 and 9
Mental health: parent-reported
Assessed at months 0, 3 and 9
- +46 more other outcomes
Study Arms (2)
Sleep extension
EXPERIMENTALThe sleep extension group (n=71) will receive a behavioral intervention focusing on parents putting their children to bed earlier by 60-90 minutes. Parents will be instructed only to alter their children's daily sleeping routine, and not to directly alter their diet and physical activity habits. Children and their parents will receive a behavioral intervention consisting of 6 sessions, including both in-person and virtual sessions, which will be scheduled based on the family's availability and to accommodate practicalities.
Control
NO INTERVENTIONThe control group (n=71) will follow their habitual sleeping schedule. Parents will be instructed not to alter their children's daily sleeping routine, or their diet and physical activity habits. The same number and frequency of meetings (in-person or virtual) and methods of registration of bedtime/wake-up times will be used as in the sleep extension group. These meetings will be educational in nature and focus on general well-being and informing the families about the home registrations of e.g., sleep and dietary intake.
Interventions
The sleep extension group will receive a behavioral intervention focusing on parents putting their children to bed earlier by 60-90 minutes. Previous studies have found this change in daily sleeping routine to be feasible and to result in 40-45 min more actual sleep. Children and their parents will receive a behavioral intervention consisting of 6 sessions, including both in-person and virtual sessions, which will be scheduled based on the family's availability and to accommodate practicalities, e.g., potential sickness or cancellations. The first two sessions will occur at the beginning of the study. These initial sessions will focus on effective behavioral strategies to enhance sleep time, including goal setting (e.g., bedtimes and wake-up times), problem-solving and preplanning, stimulus control (i.e., sleep hygiene recommendations), and positive reinforcement. Subsequent sessions will be planned with the families to occur regularly during the 12-week intervention.
Eligibility Criteria
You may qualify if:
- Age: 6-12 years old (inclusive range).
- Weight status: having a BMI above average, defined as an age- and sex-specific BMI Z-score above zero using reference standards from the WHO.
- Sleep duration: sleeping ≤9 h/night on the basis of sleep diaries filled in by the children's parents, based on recommendations by the American Academy of Sleep Medicine and the Sleep Health Foundation.
You may not qualify if:
- Any genetic, neurological, endocrinological or psychiatric condition that affects growth, metabolism, eating behaviors, cognitive function, or body weight (for example: dwarfism, epilepsy, attention deficit hyperactivity disorder, head trauma, β-thalassemia, hypothyroid-ism, hyperthyroidism, type I diabetes).
- Any sleep-related disorder (for example: obstructive sleep apnea, parasomnias, narcolepsy, restless leg syndrome).
- Regular use of prescribed or over-the-counter medications that influence study outcomes.
- Irregular school schedule.
- If a child's parents live separately, the child is allowed to sleep at both households. How-ever, if one of the parents does not wish to carry out the sleep intervention and follow given instructions, then the child should only sleep at their household Friday, Saturday and/or Sunday night.
- In the circumstance where the child does not speak or understand Danish, the child's parents do not have to speak or understand Danish, as long as both parties can speak and understand English.
- Participation in other research studies.
- Metal implants and claustrophobia (only for substudy-II).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Copenhagenlead
- Novo Nordisk Foundation (NNF)collaborator
- Faculty of Health, Medicine and Life Sciences, Maastricht Universitycollaborator
- Center for Obesity Research & Education, Temple Universitycollaborator
- Danish Research Centre for Magnetic Resonancecollaborator
- University of Southern Denmarkcollaborator
Study Sites (3)
University of Copenhagen
Copenhagen, 1958, Denmark
University of Copenhagen
Copenhagen, 2200, Denmark
Faidon Magkos
Hvidovre, 2650, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Faidon Magkos, PhD
University of Copenhagen, Department of Nutrition, Exercise and Sports
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2023
First Posted
April 2, 2024
Study Start
August 13, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2028
Last Updated
November 25, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share